Evaluation of the affect in the detection of significant prostate cancer by the characteristics of the biopsy needle

Evaluation of the affect in the detection of significant prostate cancer by the characteristics of the biopsy needle - Evaluation of the affect in the detection of significant prostate cancer by the characteristics of the biopsy needle

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041655

Enrollment

Registered

2020-10-01

Start date

2020-09-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1.Prostate cancer suspected person who are able to be receive MRI-TRUS fusion image-guided biopsy. 2.Prostate cancer suspected person with PI-RADS 4,5lesions identified on MRI. 3.Prstate cancer suspected person who agree with informed consent.

Exclusion criteria

Exclusion criteria: 1.Prstate cancer suspected person who disagree with informed consent. 2.Person who are regarded as inappropriate for the study by the researcher.

Design outcomes

Primary

Measure	Time frame
Sample quality of the prostate biopsy cores, Relationship between MRI finding and pathological findings of the prostate biopsy	—

Countries

Japan

Contacts

Public ContactMayura Nakano

Tokai University School of Medicine

mayura1212@gmail.com0463-93-1121

Outcome results